Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (31-40 of 10,647) with videos related to

Pageof 1,065
Sort By:
Current Pharmaceutical Design|March 3, 2011
Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophreniaDana V Ferraris, Takashi Tsukamoto
Current Pharmaceutical Design|June 2, 2010
What can actigraphy add to the concept of labschool design in clinical trials?Henrik Uebel, Björn Albrecht, Roumen Kirov, et al.
Current Pharmaceutical Design|July 13, 2010
Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayerJingwei Xie, Chenlu Lei, Yong Hu, et al.
Current Pharmaceutical Design|July 13, 2010
Effect of particle formulation on dry powder inhalation efficiencyMeer Saiful Hassan, Raymond Lau
Current Pharmaceutical Design|July 21, 2010
Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compoundsYovani Marrero-Ponce, Gerardo M Casañola-Martín, Mahmud Tareq Hassan Khan, et al.
Current Pharmaceutical Design|July 21, 2010
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issuesHumberto González-Díaz, Fernanda Romaris, Aliuska Duardo-Sanchez, et al.
Current Pharmaceutical Design|July 21, 2010
Ontologies of drug discovery and design for neurology, cardiology and oncologyJosé M Vázquez-Naya, Marcos Martínez-Romero, Ana B Porto-Pazos, et al.
Current Pharmaceutical Design|July 21, 2010
Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organismsRiccardo Concu, Gianni Podda, Florencio M Ubeira, et al.
Current Pharmaceutical Design|August 12, 2010
Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agentsCarles Galdeano, Elisabet Viayna, Pau Arroyo, et al.
Current Pharmaceutical Design|August 21, 2010
Targeted therapy options for treatment of bone metastases; beyond bisphosphonatesJ T Buijs, C C H J Kuijpers, G van der Pluijm
Pageof 1,065

Showing results (31-40 of 10,647) with videos related to

Sort By:
Pageof 1,065
Current Pharmaceutical Design|March 3, 2011
Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophreniaDana V Ferraris, Takashi Tsukamoto
Current Pharmaceutical Design|June 2, 2010
What can actigraphy add to the concept of labschool design in clinical trials?Henrik Uebel, Björn Albrecht, Roumen Kirov, et al.
Current Pharmaceutical Design|July 13, 2010
Nanoparticulate formulations for paclitaxel delivery across MDCK cell monolayerJingwei Xie, Chenlu Lei, Yong Hu, et al.
Current Pharmaceutical Design|July 13, 2010
Effect of particle formulation on dry powder inhalation efficiencyMeer Saiful Hassan, Raymond Lau
Current Pharmaceutical Design|July 21, 2010
Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compoundsYovani Marrero-Ponce, Gerardo M Casañola-Martín, Mahmud Tareq Hassan Khan, et al.
Current Pharmaceutical Design|July 21, 2010
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issuesHumberto González-Díaz, Fernanda Romaris, Aliuska Duardo-Sanchez, et al.
Current Pharmaceutical Design|July 21, 2010
Ontologies of drug discovery and design for neurology, cardiology and oncologyJosé M Vázquez-Naya, Marcos Martínez-Romero, Ana B Porto-Pazos, et al.
Current Pharmaceutical Design|July 21, 2010
Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organismsRiccardo Concu, Gianni Podda, Florencio M Ubeira, et al.
Current Pharmaceutical Design|August 12, 2010
Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agentsCarles Galdeano, Elisabet Viayna, Pau Arroyo, et al.
Current Pharmaceutical Design|August 21, 2010
Targeted therapy options for treatment of bone metastases; beyond bisphosphonatesJ T Buijs, C C H J Kuijpers, G van der Pluijm
Pageof 1,065